TB Research

Achieving Antiretroviral Therapy Uptake and Viral Suppression Among Children and Adolescents Living With HIV in the UNAIDS 90-90-90 Era Across Six Countries in Eastern and Southern Africa-Lessons From the BIPAI Network

Bacha JM, Dlamini S, Anabwani F, Gwimile J, Kanywa JB, Farirai J, Bvumbwe M, Steffy T, et al. (11 authors)

Journal of acquired immune deficiency syndromes (1999) · 2022-07

Abstract

Background Although achievements have been made globally since the UNAIDS 90-90-90 targets were announced, paediatric data remain sparse. We describe achievements toward antiretroviral therapy (ART) uptake and viral load (VL) suppression, existing gaps, and potential best practices among children and adolescents living with HIV (CALHIV) across 6 Eastern and Southern African countries. Setting Baylor College of Medicine International Paediatric AIDS Initiative Network sites in Botswana, Eswatini, Lesotho, Malawi, Tanzania, and Uganda. Methods We performed retrospective data analysis among CALHIV ages 0-19 years between 2014 and 2019. Results A total of 25,370 CALHIV received care, 85.8% (21,773/25,370) received ART, 84.4% (18,376/21,773) had documented VL results, and 74.6% (13,715/18,376) had VL Conclusions High rates of CALHIV receiving ART and having viral suppression can be achieved in settings in Eastern and Southern Africa through using pediatric best practices. Increased efforts must be made to address LTFU and to support under-fives and adolescents.

MeSH terms

  • Humans
  • HIV Infections
  • Anti-HIV Agents
  • Viral Load
  • Retrospective Studies
  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Infant
  • Infant, Newborn
  • Tanzania
  • Young Adult